Skip to main content

. 1983 Feb 19;286(6365):605–606. doi: 10.1136/bmj.286.6365.605-a

Long term consequences of arsenical treatment for multiple sclerosis.

D A Robertson, T S Low-Beer

PMCID: PMC1546829 PMID: 6218862

605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Datta D. V., Mitra S. K., Chhuttani P. N., Chakravarti R. N. Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut. 1979 May;20(5):378–384. doi: 10.1136/gut.20.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
Morris J. S., Schmid M., Newman S., Scheuer P. J., Sherlock S. Arsenic and noncirrhotic portal hypertension. Gastroenterology. 1974 Jan;66(1):86–94. [PubMed] [Google Scholar]

ACTIONS

RESOURCES